S. Cepok

发表

Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

J. Newcombe, R. Ransohoff, M. Krumbholz, 2006, Brain : a journal of neurology.

Validation of Plasma Branched Chain Amino Acids as Biomarkers in Huntington Disease

F. Zipp, M. Goldman, S. Cepok, 2017 .

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Simon C. Potter, Joseph T. Glessner, M. Pirinen, 2011, Nature.

HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis

P. Stadler, H. Hartung, S. Cepok, 2008, American Journal of Human Genetics.

HLA-DRB1∗0401 and HLA-DRB1∗0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis

P. Stadler, H. Hartung, S. Cepok, 2008, The American Journal of Human Genetics.

Immune surveillance in multiple sclerosis patients treated with natalizumab

S. Cepok, B. Hemmer, C. Marra, 2006, Annals of neurology.

Etiology and site of temporal lobe epilepsy influence postictal cytokine release

W. Oertel, H. Hamer, F. Rosenow, 2009, Epilepsy Research.

EASY-HIT: HIV Full-Replication Technology for Broad Discovery of Multiple Classes of HIV Inhibitors

S. Cepok, B. Hemmer, J. Durner, 2010, Antimicrobial Agents and Chemotherapy.

oooooooooooooooooooooooooooooooo Sympatric Mouse Lemurs in North-West Madagascar: A New Rufous Mouse Lemur Species (Microcebus ravelobensis)

S. Cepok, E. Zimmermann, U. Radespiel, 1998 .

Sex‐specific usage patterns of sleeping sites in grey mouse lemurs (Microcebus murinus) in northwestern Madagascar

S. Cepok, E. Zimmermann, U. Radespiel, 1998, American journal of primatology.

Sympatric Mouse Lemurs in Nort-West Madagascar: A New Rufous Mouse Lemur Species (Microcebus ravelobensis)

S. Cepok, U. Radespiel, N. Rakotoarison, 1998, Folia Primatologica.

Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses

S. Cepok, B. Hemmer, H. Tumani, 2010, Neurochemistry International.

Interictal alterations of cytokines and leukocytes in patients with active epilepsy

W. Oertel, H. Hamer, F. Rosenow, 2011, Brain, Behavior, and Immunity.

NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsy

W. Oertel, H. Hamer, F. Rosenow, 2008, Experimental Neurology.

Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid

L. Hofbauer, S. Cepok, B. Hemmer, 2004, Acta Neuropathologica.

Identification of Target Antigens in CNS Inflammation by Protein Array Technique

K. Büssow, S. Cepok, B. Hemmer, 2007 .

The antibody response to oligodendrocyte specific protein in multiple sclerosis

S. Cepok, B. Hemmer, D. Buck, 2010, Journal of Neuroimmunology.

Antibody responses to EBV and native MOG in pediatric inflammatory demyelinating CNS diseases

S. Cepok, B. Hemmer, R. Dale, 2010, Neurology.

Accumulation of class switched IgD−IgM− memory B cells in the cerebrospinal fluid during neuroinflammation

H. Hartung, S. Cepok, B. Hemmer, 2006, Journal of Neuroimmunology.

The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis.

S. Cepok, B. Hemmer, B. Rosche, 2003, Archives of Neurology.

Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS

S. Cepok, B. Hemmer, R. Hohlfeld, 2011, Neurology.

Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis

Christian Gieger, Bernhard Hemmer, Achim Berthele, 2013, Annals of neurology.

Varicella zoster virus is not a disease‐relevant antigen in multiple sclerosis

S. Cepok, B. Hemmer, J. Bennett, 2009, Annals of neurology.

A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule

A. Ziegler, S. Cepok, B. Hemmer, 2002, Immunogenetics.

Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

A. Bar-Or, F. Grand'Maison, S. Cepok, 2006 .

Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease

S. Cepok, B. Hemmer, D. Zhou, 2009, Annals of neurology.

The role of antibodies in multiple sclerosis.

S. Cepok, B. Hemmer, Martin S. Weber, 2011, Biochimica et biophysica acta.

New immunopathologic insights into multiple sclerosis

H. Hartung, S. Cepok, B. Hemmer, 2003, Current neurology and neuroscience reports.

New approaches to dissect degeneracy and specificity in T cell antigen recognition

Bernhard Hemmer, Wolfgang H. Oertel, Norbert Sommer, 2001, Journal of Molecular Medicine.

The role of the Epstein–Barr Virus receptor CD21 in Multiple Sclerosis

S. Cepok, B. Hemmer, V. Grummel, 2012, Journal of Neuroimmunology.

More CLEC16A gene variants associated with multiple sclerosis

F. Holsboer, B. Müller-Myhsok, S. Cepok, 2011, Acta neurologica Scandinavica.

Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis

F. Holsboer, B. Müller-Myhsok, S. Cepok, 2010, Journal of Neuroimmunology.

The role of the Polio Virus Receptor and the Herpesvirus entry mediator B genes for the development of MS

S. Cepok, B. Hemmer, S. Hoffmann, 2004, Journal of Neuroimmunology.

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients.

A. Ziegler, W. Oertel, S. Cepok, 2002, Brain : a journal of neurology.

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis.

H. Hartung, S. Cepok, B. Hemmer, 2005, Brain : a journal of neurology.

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

K. Büssow, S. Cepok, B. Hemmer, 2005, The Journal of clinical investigation.

IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci

C. Gieger, M. Daly, L. Peltonen, 2010, Genes and Immunity.

Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis.

W. Oertel, S. Cepok, B. Hemmer, 2001, Brain : a journal of neurology.

Viral load determines the B‐cell response in the cerebrospinal fluid during human immunodeficiency virus infection

H. Hartung, S. Cepok, B. Hemmer, 2007, Annals of neurology.

CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals.

H. Hartung, S. Cepok, B. Hemmer, 2007, AIDS.

Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis

H. Hartung, S. Cepok, B. Hemmer, 2005 .

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

S. Cepok, B. Hemmer, T. Korn, 2012, Journal of Neuroinflammation.

Single-nucleotide polymorphisms in HLA- and non-HLA genes associated with the development of antibodies to interferon-β therapy in multiple sclerosis patients

F. Holsboer, H. Hartung, B. Müller-Myhsok, 2011, The Pharmacogenomics Journal.

Influence of the HLA-DRB1 genotype on antibody development to interferon beta in multiple sclerosis.

H. Hartung, S. Cepok, B. Hemmer, 2011, Archives of neurology.

Population structure and HLA DRB1*1501 in the response of subjects with multiple sclerosis to first-line treatments

H. Weiner, D. Hafler, S. Cepok, 2011, Journal of Neuroimmunology.

Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.

H. Hartung, S. Cepok, B. Hemmer, 2009, Archives of neurology.

CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions

J. Newcombe, M. Krumbholz, D. Theil, 2007, Journal of Neuroimmunology.

High throughput analysis of TCR-β rearrangement and gene expression in single T cells

Bernhard Hemmer, Hans-Peter Hartung, Rajneesh Srivastava, 2006, Laboratory Investigation.

Pathogenesis of multiple sclerosis: an update on immunology

S. Cepok, B. Hemmer, S. Nessler, 2002, Current opinion in neurology.

The Genetic Association of Variants in CD6, TNFRSF1A and IRF8 to Multiple Sclerosis: A Multicenter Case-Control Study

L. Peltonen, A. Goris, S. Sawcer, 2011, PloS one.

Digger wasp versus cricket: mechanisms underlying the total paralysis caused by the predator's venom.

M. Hörner, S. Cepok, W. Gnatzy, 2001, Journal of neurobiology.

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.

T. Montine, S. Cepok, B. Hemmer, 2009, Archives of neurology.

Myositis in a patient with large granular leukocyte leukemia

S. Cepok, B. Hemmer, M. Jacobsen, 2004, Muscle & nerve.

IL 12 A , MPHOSPH 9 / CDK 2 AP 1 and RGS 1 are novel multiple sclerosis susceptibility loci

Winkelmann, L. Peltonen, M. Pericak-Vance, 2010 .

Altered CD 4 / CD 8 T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

A. Bar-Or, F. Grand'Maison, S. Cepok, 2006 .

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.

H. Hartung, S. Cepok, B. Hemmer, 2005, Archives of neurology.

No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.

F. Zipp, M. Goldman, S. Cepok, 2011, Archives of neurology.

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

D. Miller, S. Cepok, B. Hemmer, 2009, Neurology.

NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptors

S. Cepok, J. Spiess, T. Blank, 1999, Brain Research.

Neurofilament ELISA validation.

Bernhard Hemmer, Gavin Giovannoni, Johannes Kornhuber, 2010, Journal of immunological methods.

Clonal accumulation of activated CD8+ T cells in the central nervous system during the early phase of neuroborreliosis.

S. Cepok, B. Hemmer, M. Jacobsen, 2003, The Journal of infectious diseases.

Multiple sclerosis -- a coordinated immune attack across the blood brain barrier.

S. Cepok, B. Hemmer, N. Sommer, 2004, Current neurovascular research.

Comparison Between Impact Factors and Citations in Evidence-Based Practice Guidelines

C. Polman, B. Uitdehaag, S. Cepok, 2017 .